Evidence map›Paper›PMID 26900925›Full record

ArticleNature neuroscience2016

Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum.

Daniela B Pereira, Yvonne Schmitz, József Mészáros, Paolomi Merchant, Gang Hu, Shu Li, Adam Henke, José E Lizardi-Ortiz, Richard J Karpowicz, Travis J Morgenstern and 6 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 182 citations in OpenAlex.

  1. Article
  2. Altered striatal dopamine regulation in Adgrl3 knockout mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Distinct forms of dopamine transmission control locomotion and learning.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Membrane Merger Dynamics in Exocytosis and Endocytosis.Advances in experimental medicine and biology · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Daniela B PereiraDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Yvonne SchmitzDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
József MészárosDepartment of Psychiatry, Columbia University Medical Center, New York, New York, USA.
Paolomi MerchantDepartment of Chemistry, Columbia University, New York, New York, USA.
Gang HuDepartment of Chemistry, Columbia University, New York, New York, USA.
Shu LiDepartment of Chemistry, Columbia University, New York, New York, USA.
Adam HenkeDepartment of Chemistry, Columbia University, New York, New York, USA.
José E Lizardi-OrtizDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Richard J KarpowiczDepartment of Chemistry, Columbia University, New York, New York, USA.
Travis J MorgensternDepartment of Pharmacology, Columbia University Medical Center, New York, New York, USA.
Mark S SondersDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Ellen KanterDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Pamela C RodriguezDepartment of Chemistry, Columbia University, New York, New York, USA.
Eugene V MosharovDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Dalibor SamesDepartment of Chemistry, Columbia University, New York, New York, USA.
David SulzerDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · USColumbia University · USNew York Psychoanalytic Society and Institute · US

Funding

TRANSLATIONAL APPROACHES TO NEUROPROTECTION OF AXONS IN PDrP50NS038370 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BURKE, ROBERT E · 1999 to 2014
$24.0M
The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, KREITZER, ANATOL · 1995 to 2016
$14.7M
The Dopamine Synapse and Associative LearningR01DA007418 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David Sulzer · 1999 to 2026
$9.4M
Development of Fluorescent False NeurotransmittersR01MH108186 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR, SULZER, DAVID · 2015 to 2024
$5.8M
ADVANCED GRADUATE TRAINING PROGRAM IN NEUROBIOLOGY & BEHAVIORT32NS064928 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENGST, ULRICH · 2010 to 2024
$3.0M
Alcohol and Dopamine Release: Cellular and Synaptic MechanismsR01AA019801 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARRISON, NEIL L., SULZER, DAVID · 2010 to 2014
$1.8M
Interaction between DA, alpha-Synuclein and Chaperone-Mediated AutophagyR01NS075222 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOSHAROV, EUGENE V · 2011 to 2015
$1.7M
Design of Molecular Probes For Optical Imaging of Dopamine NeurotransmissionR01MH086545 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR · 2010 to 2013
$1.5M
AMPHETAMINE ACTION MESOLIMBIC DOPAMINE NEURONAL CULTURER29DA007418 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SULZER, DAVID · 1991 to 1995
–
AMPHETAMINE ACTION IN MIDBRAIN DOPAMINE NEURONAL CULTURER55DA007418 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI SULZER, DAVID · 1996 to 1996
–
NIAAA NIH HHS AA019801NIAAA NIH HHS R01 AA019801NIDA NIH HHS DA07418NIDA NIH HHS DA10154NIDA NIH HHS P01 DA010154NIDA NIH HHS R01 DA007418NIMH NIH HHS R01 MH086545NIMH NIH HHS R01MH086545NIMH NIH HHS R01 MH108186NIMH NIH HHS R01MH108186NINDS NIH HHS 3 P50 NS 038370-13S1NINDS NIH HHS P50 NS038370NINDS NIH HHS R01 NS075222NINDS NIH HHS R01NS075222NINDS NIH HHS T32 NS064928
6 · The paper itself

Abstract

Neurotransmission at dopaminergic synapses has been studied with techniques that provide high temporal resolution, but cannot resolve individual synapses. To elucidate the spatial dynamics and heterogeneity of individual dopamine boutons, we developed fluorescent false neurotransmitter 200 (FFN200), a vesicular monoamine transporter 2 (VMAT2) substrate that selectively traces monoamine exocytosis in both neuronal cell culture and brain tissue. By monitoring electrically evoked Ca(2+) transients with GCaMP3 and FFN200 release simultaneously, we found that only a small fraction of dopamine boutons that exhibited Ca(2+) influx engaged in exocytosis, a result confirmed with activity-dependent loading of the endocytic probe FM1-43. Thus, only a low fraction of striatal dopamine axonal sites with uptake-competent VMAT2 vesicles are capable of transmitter release. This is consistent with the presence of functionally 'silent' dopamine vesicle clusters and represents, to the best of our knowledge, the first report suggestive of presynaptically silent neuromodulatory synapses.

Indexed as

AnimalsCells, CulturedCorpus StriatumDopamineExocytosisFemaleFluorescent DyesHEK293 CellsHumansMaleMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicNeurotransmitter AgentsDopamineFluorescent DyesNeurotransmitter Agents

Identifiers

PMID26900925
PMCPMC4853199
OpenAlexW2287361610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.